SEC Form 4 · accession 0001642247-17-000009
Perspective Therapeutics, Inc. · CATX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Thomas C Lavoy
Officer — CEO · Director
Period of report
Jun 15, 2017
Accepted (ET)
Jun 29, 2017 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000728387
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.69 | Jun 15, 2017 | D | 250,000 | D | — | Feb 15, 2026 | Common Stock | 250,000 | 0 | D |
| Stock Options (right to buy)F1 | $0.93 | Jun 15, 2017 | D | 100,000 | D | — | Jun 21, 2026 | Common Stock | 100,000 | 0 | D |
| Stock Options (right to buy)F1,F2 | $0.605 | Jun 27, 2017 | A | 715,000 | A | — | Jun 27, 2027 | Common Stock | 715,000 | 0 | D |
Explanation of responses
- F1The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option.
- F225% vested as of 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested.